RN486 是一种有效、选择性、口服活性的Btk 抑制剂,IC50 为 4.0 nM,Kd 为 0.31 nM,对其他激酶活性较低, 可用于类风湿性关节炎和系统性红斑狼疮的研究。


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 产品名称 | BTK ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CGI-1746 |
+++
BTK, IC50: 1.9 nM |
98% | |||||||||||||||||
| Spebrutinib |
++++
BTK, IC50: <0.5 nM |
98+% | |||||||||||||||||
| Acalabrutinib |
++
BTK, IC50: 3nM |
98% | |||||||||||||||||
| CNX-774 |
+++
BTK, IC50: <1 nM |
99%+ | |||||||||||||||||
| Ibrutinib |
++++
BTK, IC50: 0.5 nM |
98% | |||||||||||||||||
| ONO-4059 analog |
+
BTK, IC50: 23.9 nM |
98% | |||||||||||||||||
| RN486 |
++
BTK, IC50: 4 nM |
99%+ | |||||||||||||||||
| (Z)-LFM-A13 |
+
BTK, Ki: 1.4 μM |
99%+ | |||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 靶点 |
|
| 描述 | RN486 is a selective Btk inhibitor with an IC50 Value of 4.0 nM. |
| Concentration | Treated Time | Description | References | |
| HEK293/B1G2 | 0.3, 1, 3 μM | 68 hours | To evaluate the reversal effect of RN486 on ABCG2-overexpressing cancer cells, results showed that RN486 significantly increased the sensitivity of ABCG2-overexpressing cells to mitoxantrone and topotecan. | J Transl Int Med. 2024 Jul 27;12(3):288-298. |
| HEK293/G2 | 0.3, 1, 3 μM | 68 hours | To evaluate the reversal effect of RN486 on ABCG2-overexpressing cancer cells, results showed that RN486 significantly increased the sensitivity of ABCG2-overexpressing cells to mitoxantrone and topotecan. | J Transl Int Med. 2024 Jul 27;12(3):288-298. |
| HEK293/B1 | 0.3, 1, 3 μM | 68 hours | To evaluate the reversal effect of RN486 on ABCG2-overexpressing cancer cells, results showed that RN486 significantly increased the sensitivity of ABCG2-overexpressing cells to mitoxantrone and topotecan. | J Transl Int Med. 2024 Jul 27;12(3):288-298. |
| HEK293/PEL | 0.3, 1, 3 μM | 68 hours | To evaluate the reversal effect of RN486 on ABCG2-overexpressing cancer cells, results showed that RN486 significantly increased the sensitivity of ABCG2-overexpressing cells to mitoxantrone and topotecan. | J Transl Int Med. 2024 Jul 27;12(3):288-298. |
| S1-M1-80 | 0.3, 1, 3 μM | 68 hours | To evaluate the reversal effect of RN486 on ABCG2-overexpressing cancer cells, results showed that RN486 significantly increased the sensitivity of ABCG2-overexpressing cells to mitoxantrone and topotecan. | J Transl Int Med. 2024 Jul 27;12(3):288-298. |
| S1 | 0.3, 1, 3 μM | 68 hours | To evaluate the reversal effect of RN486 on ABCG2-overexpressing cancer cells, results showed that RN486 significantly increased the sensitivity of ABCG2-overexpressing cells to mitoxantrone and topotecan. | J Transl Int Med. 2024 Jul 27;12(3):288-298. |
| NCI-H460/MX20 | 0.3, 1, 3 μM | 68 hours | To evaluate the reversal effect of RN486 on ABCG2-overexpressing cancer cells, results showed that RN486 significantly increased the sensitivity of ABCG2-overexpressing cells to mitoxantrone and topotecan. | J Transl Int Med. 2024 Jul 27;12(3):288-298. |
| NCI-H460 | 0.3, 1, 3 μM | 68 hours | To evaluate the reversal effect of RN486 on ABCG2-overexpressing cancer cells, results showed that RN486 significantly increased the sensitivity of ABCG2-overexpressing cells to mitoxantrone and topotecan. | J Transl Int Med. 2024 Jul 27;12(3):288-298. |
| NCI-H2228 | 10 μM | 72 hours | Evaluate the effect of RN486 on cell viability, results showed RN486 significantly decreased cell viability | J Exp Clin Cancer Res. 2019 Jun 14;38(1):260. |
| NCI-H1975 | 10 μM | 72 hours | Evaluate the effect of RN486 on cell viability, results showed RN486 significantly decreased cell viability | J Exp Clin Cancer Res. 2019 Jun 14;38(1):260. |
| Calu-6 | 10 μM | 72 hours | Evaluate the effect of RN486 on cell viability, results showed RN486 significantly decreased cell viability | J Exp Clin Cancer Res. 2019 Jun 14;38(1):260. |
| SK-Lu-1 | 10 μM | 72 hours | Evaluate the effect of RN486 on cell viability, results showed RN486 significantly decreased cell viability | J Exp Clin Cancer Res. 2019 Jun 14;38(1):260. |
| Murine neonatal cardiomyocytes (CMs) | 25 μM | 24 hours | To evaluate the protective effect of NG-R1 on hypoxia/reoxygenation-induced apoptosis. Results showed that NG-R1 significantly inhibited apoptosis, reduced LDH release, and improved cell viability. | Front Cell Dev Biol. 2020 Aug 27;8:865. |
| Administration | Dosage | Frequency | Description | References | ||
| C57/BL6 mice | Myocardial ischemia/reperfusion injury model | Intraperitoneal injection | 25 mg/kg | Every 2 hours for a total of 3 times, starting 30 minutes before ischemic surgery | To evaluate the protective effect of NG-R1 on myocardial ischemia/reperfusion injury. Results showed that NG-R1 significantly reduced myocardial infarction area, alleviated myocardial cell damage, and improved cardiac function. | Front Cell Dev Biol. 2020 Aug 27;8:865. |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
1.65mL 0.33mL 0.16mL |
8.24mL 1.65mL 0.82mL |
16.48mL 3.30mL 1.65mL |
|
| CAS号 | 1242156-23-5 |
| 分子式 | C35H35FN6O3 |
| 分子量 | 606.69 |
| SMILES Code | O=C1N(C2=CC=CC(C(C=C3NC4=NC=C(N5CCN(C)CC5)C=C4)=CN(C)C3=O)=C2CO)C=CC6=C1C(F)=CC(C7CC7)=C6 |
| MDL No. | MFCD24682729 |
| 别名 | |
| 运输 | 蓝冰 |
| InChI Key | ZTUJNJAKTLHBEX-UHFFFAOYSA-N |
| Pubchem ID | 46908026 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Keep in dark place, sealed in dry, 2-8°C |
| 溶解方案 |
DMSO: 20 mg/mL(32.97 mM),配合低频超声,并水浴加热至45℃助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO |
沪公网安备 31011702889066号
沪ICP备2024050318号-1